Compare · HPCO vs TLRY
HPCO vs TLRY
Side-by-side comparison of Hempacco Co. Inc. (HPCO) and Tilray Brands Inc. (TLRY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HPCO and TLRY operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- TLRY carries a market cap of $2.44B.
- Over the past year, HPCO is up 0.0% and TLRY is up 41.0% - TLRY leads by 41.0 points.
- TLRY has hit the wire 12 times in the past 4 weeks while HPCO has been quiet.
- TLRY has more recent analyst coverage (14 ratings vs 0 for HPCO).
- Company
- Hempacco Co. Inc.
- Tilray Brands Inc.
- Price
- $0.62-11.65%
- $6.74-2.67%
- Market cap
- -
- $2.44B
- 1M return
- +0.00%
- -3.23%
- 1Y return
- +0.00%
- +40.96%
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2022
- 2018
- News (4w)
- 0
- 12
- Recent ratings
- 0
- 14
Tilray Brands Inc.
Tilray, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. The company operates through five segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, and Business Under Development. It provides medical and adult-use cannabis products; pharmaceutical and wellness products; beverage alcohol products; and hemp-based food and other wellness products. The company offers its products to retailers, wholesalers, patients, physicians, pharmacies, clinics, hospitals, governments, and researchers. It has operations in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company was formerly known as Aphria Inc. Tilray, Inc. was incorporated in 2018 and is based in New York, New York.
Latest HPCO
- Hempacco Co. Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Hempacco Co. Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- Hempacco Co. Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- Hempacco Co. Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Unregistered Sales of Equity Securities
- SEC Form NT 10-Q filed by Hempacco Co. Inc.
- SEC Form DEFA14A filed by Hempacco Co. Inc.
- SEC Form DEF 14A filed by Hempacco Co. Inc.
- Hempacco Co. Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- SEC Form 10-K filed by Hempacco Co. Inc.
- Hempacco Co. Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Latest TLRY
- Tilray Brands Positioned for U.S. Expansion Amid Historic Cannabis Rescheduling
- BrewDog USA Doubles Down on Headliners and Ignites Next Wave of Innovation for Spring and Summer
- SEC Form 4 filed by Hopkinson David G.
- Tilray Brands Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- SEC Form 424B7 filed by Tilray Brands Inc.
- Tilray Brands Marks 4/20, Reaffirming Its Leadership in Cannabis and Commitment to Advancing Medical Care
- SEC Form 424B5 filed by Tilray Brands Inc.
- Tilray Brands Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- Tilray Brands Accelerates Next Phase of Global Growth and Market Leadership
- Tilray Brands Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities